Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
47,601,550
-
Total 13F shares
-
30,834,019
-
Share change
-
+7,716,313
-
Total reported value
-
$895,742,171
-
Price per share
-
$29.05
-
Number of holders
-
68
-
Value change
-
+$247,196,632
-
Number of buys
-
55
-
Number of sells
-
15
Institutional Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q1 2021
As of 31 Mar 2021,
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,834,019 shares.
The largest 10 holders included
Blackstone Group Inc., BVF INC/IL, Avidity Partners Management LP, EVENTIDE ASSET MANAGEMENT, LLC, Soleus Capital Management, L.P., Vivo Capital, LLC, Bellevue Group AG, JANUS HENDERSON GROUP PLC, ADAGE CAPITAL PARTNERS GP, L.L.C., and FMR LLC.
This page lists
68
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.